Neo Ivy Capital Management’s AbbVie ABBV Stock Holding History

Neo Ivy Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$881K	Buy	+3,502	New	+$753K	0.2%	166
2026 Q1	–	Sell	-1,754	Closed	-$401K	–	316
2025 Q4	$401K	Buy	+1,754	New	+$400K	0.06%	215
2025 Q2	–	Sell	-896	Closed	-$188K	–	345
2025 Q1	$188K	Buy	+896	New	+$174K	0.06%	222
2023 Q3	–	Sell	-894	Closed	-$120K	–	308
2023 Q2	$120K	Buy	+894	New	+$131K	0.06%	231
2022 Q4	–	Sell	-1,174	Closed	-$158K	–	313
2022 Q3	$158K	Buy	+1,174	New	+$168K	0.42%	93
2022 Q2	–	Sell	-546	Closed	-$88K	–	383
2022 Q1	$88K	Buy	+546	New	+$79.3K	0.08%	317
2021 Q3	–	Sell	-2,222	Closed	-$250K	–	439
2021 Q2	$250K	Sell	2,222 -1,480	-40%	-$167K	0.25%	149
2021 Q1	$401K	Buy	+3,702	New	+$396K	0.44%	69
2020 Q4	–	Sell	-4,514	Closed	-$395K	–	400
2020 Q3	$395K	Buy	+4,514	New	+$425K	0.4%	79
2020 Q2	–	Sell	-3,253	Closed	-$248K	–	440
2020 Q1	$248K	Sell	3,253 -421	-11%	-$35.9K	0.4%	82
2019 Q4	$325K	Buy	+3,674	New	+$305K	0.38%	120
2019 Q3	–	Sell	-3,214	Closed	-$234K	–	273
2019 Q2	$234K	Sell	3,214 -7,155	-69%	-$562K	0.13%	197
2019 Q1	$835K	Buy	+10,369	New	+$848K	0.47%	95

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Neo Ivy Capital Management's ABBV Position: Q2 2026 in Review

Neo Ivy Capital Management opened a new position in AbbVie (ABBV) in Q2 2026: 3,502 shares worth $881K. The stake represents 0.2% of the portfolio and ranks #166 among its holdings. This is a return to the name: Neo Ivy Capital Management previously reported a position in ABBV as recently as Q4 2025.

Neo Ivy Capital Management first reported a position in ABBV in Q1 2019 and has held it in 13 quarters since. 4,231 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Neo Ivy Capital Management held 3,502 shares of AbbVie worth $881K as of Q2 2026.
AbbVie was a new Neo Ivy Capital Management position in Q2 2026.
AbbVie made up 0.2% of Neo Ivy Capital Management's portfolio in Q2 2026, its #166 holding.
Neo Ivy Capital Management first reported a position in AbbVie in Q1 2019 and has held it in 13 quarters since.
4,231 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Neo Ivy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.